Fundz

Avenue Biosciences raised €2.3 million in a seed funding round led by Voima Ventures to accelerate the development of their AI-enhanced protein engineering platform.

PRIVATEOct 22, 2024

Amount Raised

€2.3 Million

Round Type

Seed

ManufacturingBiotechnology

Investors

InventureVoima Ventures

Description

Avenue Biosciences announced the successful closing of their €2.3 million seed financing round. The funding will accelerate the development of their platform designed to improve the efficiency of protein production in the biopharmaceutical industry.

Quick answer

Avenue Biosciences raised €2.3 Million in a Seed round, dated October 22, 2024. Investors: Inventure and Voima Ventures.

How much did Avenue Biosciences raise?
Avenue Biosciences raised €2.3 Million in a Seed round on October 22, 2024.
Who invested in Avenue Biosciences?
Inventure and Voima Ventures are named as investors in this round.
What does Avenue Biosciences do?
Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers.
Where is Avenue Biosciences based and how big is it?
Fundz records about 17 employees.
Who are the decision-makers at Avenue Biosciences?
Fundz holds 3 contacts at Avenue Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Avenue Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Micropep Technologies raised $40M (Series B) on December 6, 2024.
  • Scorpius raised $13M on December 6, 2024.
  • Nature's Toolbox raised $15M (Funding Round) on December 4, 2024.
  • miDiagnostics raised $32M (Series D) on December 4, 2024.
  • Enzo Life Sciences raised $8.3M on December 3, 2024.
  • OSSIO raised $28M on December 2, 2024.

Who to call at Avenue Biosciences, and when

A new round usually means Avenue Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Avenue Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Avenue Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Avenue Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Avenue Biosciences

About

Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biology and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, and unlock new therapeutic possibilities.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Avenue Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Avenue Biosciences's next move

See what Strategic adds

Avenue Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.